[{"Assets_0_Q1_USD":"989799000.0","CIK":"1743881","CommonStockSharesConverted_0_Q1_shares":"123774536.0","CommonStockSharesOutstanding_0_Q1_shares":"121359855.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.78","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q1_USD":"68303000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-83920000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-91850000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q1_USD":"-104082000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"449018000.0","StockholdersEquity_0_Q1_USD":"380715000.0","Ticker":"BBIO","filed":"20200514","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"BRIDGEBIO PHARMA, INC.","period":"20200331","qtrs":"0","uom":"USD"}]